×
About 755 results

ALLMedicine™ Behçet Disease Center

Research & Reviews  279 results

Association between Serum α-Klotho Levels and Behçet Disease.
https://doi.org/10.1093/labmed/lmac146
Laboratory Medicine; Jafari Nakhjavani MR, Ghorbanihaghjo A et. al.

Jan 14th, 2023 - Endothelial dysfunction (ED) has a well-known role in promoting vascular inflammation in Behçet disease (BD). α-klotho is involved in regulation of endothelial function, and its reduction has been reported to be associated with ED. To assess serum...

Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital
https://clinicaltrials.gov/ct2/show/NCT05683626

Jan 13th, 2023 - Study design: Prospective cohort study. Sample size: 40 eyes of adult patients with complete Behçet's disease associated uveitis either male or female will be included in the study. Inclusion Criteria: Adult patients with complete Behçet's disease...

Behcet disease: an undifferentiating and complex vasculitis.
https://doi.org/10.1080/00325481.2022.2159205
Postgraduate Medicine; Pak D, Park HJ

Dec 20th, 2022 - Behçet Disease is a relapsing and remitting variable vessel vasculitis characterized by recurrent mucocutaneous ulcers that can involve almost every organ system in the body. Indeed, the presence of recurrent oral or genital ulcers with other auto...

Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients
https://clinicaltrials.gov/ct2/show/NCT04645420

Dec 19th, 2022 - INTRODUCTION 1.1 BACKGROUND Psoriasis and Psoriatic Arthritis Psoriasis is a chronic relapsing immunologically mediated skin disease manifesting as red scaly plaques, which affects about 1-3% of the population.(ref.1-3). Ten to 20% of the people w...

Teaching NeuroImage: Mobile Hypopyon as a Clinical Clue for the Diagnosis of Behçet Dis...
https://doi.org/10.1212/WNL.0000000000201577
Neurology Melo de Almeida I, Rezende Filho FM et. al.

Nov 11th, 2022 - Teaching NeuroImage: Mobile Hypopyon as a Clinical Clue for the Diagnosis of Behçet Disease.|2022|Melo de Almeida I,Rezende Filho FM,Pedroso JL,Barsottini O,|

see more →

Guidelines  1 results

EULAR recommendations for the management of Behçet disease.
https://doi.org/10.1136/ard.2007.080432
Annals of the Rheumatic Diseases; Hatemi G, Silman A et. al.

Feb 5th, 2008 - To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion. The multidisciplinary expert committee, a task force of the EULAR Standi...

see more →

Clinicaltrials.gov  9 results

Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital
https://clinicaltrials.gov/ct2/show/NCT05683626

Jan 13th, 2023 - Study design: Prospective cohort study. Sample size: 40 eyes of adult patients with complete Behçet's disease associated uveitis either male or female will be included in the study. Inclusion Criteria: Adult patients with complete Behçet's disease...

Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients
https://clinicaltrials.gov/ct2/show/NCT04645420

Dec 19th, 2022 - INTRODUCTION 1.1 BACKGROUND Psoriasis and Psoriatic Arthritis Psoriasis is a chronic relapsing immunologically mediated skin disease manifesting as red scaly plaques, which affects about 1-3% of the population.(ref.1-3). Ten to 20% of the people w...

A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
https://clinicaltrials.gov/ct2/show/NCT04609397

Jun 21st, 2022 - this study is a phase 2, multi-center, randomized, placebo-controlled, double-blind, parallel-group study to evaluate Hemay005 efficacy and safety of the treatment of patients with Behçet Disease(BD). Around 252 subjects will be randomized into th...

Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease
https://clinicaltrials.gov/ct2/show/NCT05142995

Dec 3rd, 2021 - Behçet's disease (BD) was first described by Turkish dermatologist Hulusi Behçet in 1937 as a triad of recurrent oral aphthae, genital ulcerations and relapsing uveitis (1). Behçet disease (BD) is an inflammatory vasculopathy with multisystemic in...

Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
https://clinicaltrials.gov/ct2/show/NCT02648581

Nov 22nd, 2021 - Behçet disease (BD) is a chronic systemic inflammatory disorder at the crossroad between autoimmune and autoinflammatory syndromes. Two recent large genome-wide association studies (GWAS) conducted in Turkey and Japan reported association between...

see more →

News  13 results

Pain and photophobia
https://www.mdedge.com/psoriatic-arthritis-challenge-center/article/256212/psoriatic-arthritis/pain-and-photophobia

Jul 12th, 2022 - On the basis of the patient's medical history and presentation, this is probably a case of uveitis, a common extra-articular manifestation of psoriatic disease. In fact, the presence of uveitis can help distinguish PsA from osteoarthritis.

Apremilast Uses and Relevance to the Military
https://www.mdedge.com/dermatology/article/238305/psoriasis/apremilast-uses-and-relevance-military
Nathanael E. Hathaway, MD, Willis Hughes Lyford, MD

Apr 7th, 2021 - Apremilast is a small-molecule biologic approved by the US Food and Drug Administration (FDA) for use in plaque psoriasis, psoriatic arthritis, and Behçet disease. 1-6 Although apremilast is seemingly a less favorable choice for treating psoriasis.

Hairy Cell Leukemia: A Review of Epidemiology and Disease Presentation
https://www.onclive.com/view/hairy-cell-leukemia-a-review-of-epidemiology-and-disease-presentation

Dec 5th, 2020 - Introduction Hairy cell leukemia (HCL) is a rare lymphoid malignancy.1 HCL accounts for only 2% of all lymphoid leukemias, with 600 to 800 new cases diagnosed in the United States each year.1,2 The name of the disease is attributed to the appeara...

Annual Skin Check: Examining the Dermatology Headlines of 2019
https://www.mdedge.com/dermatology/article/215057/pediatrics/annual-skin-check-examining-dermatology-headlines-2019/page/0/1?channel=28253

Jan 6th, 2020 - Drug Approvals for Rare Dermatologic Diseases On July 19, 2019, apremilast, a phosphodiesterase 4 inhibitor, became the first medication approved by the FDA for the treatment of adults with oral ulcers due to Behçet disease, a rare multisystem inf.

Skill Checkup: Knee Injection
https://reference.medscape.com/viewarticle/920374

Oct 28th, 2019 - Knee pain and stiffness can be debilitating and difficult to treat. Lifestyle-limiting knee conditions may negatively affect body image and emotional well-being. Weight management, exercise/strengthening programs, physical therapy, physical modali...

see more →